New Jersey Pediatric Hematology/Oncology Research Center of Excellence (NJ PHORCE)

Rutgers Cancer Institute seeks investigators with research relevant to pediatric cancer or blood disorders to apply for Assistant to Professor, tenure-track faculty positions. Preference will be given to research that relates to the following fields: stem cell biology and transplantation; cellular therapies; immunotherapeutics; cancer predisposition syndromes; or gene therapies. However, candidates with experience in any research field related to the prevention, diagnosis, treatment, or basic biology of cancers and blood disorders affecting children and adolescents are encouraged to apply. Academic rank will be through the Rutgers Robert Wood Johnson Medical School and is commensurate with qualifications and experience.  

Essential Duties and Responsibilities:  

• New faculty are expected to establish an innovative, independent and collaborative research program addressing important, fundamental questions in the area of cancer biology.  Interdisciplinary and translational approaches are encouraged that establish collaborations with CINJ consortium faculty.
• Teaching and mentorship activities, as appropriate.
• Understands and adheres to RBHS compliance standards as they appear in RBHS (legacy UMDNJ) Corporate Compliance Policy and Code of Conduct and Conflict of Interest Policy.

The New Jersey Pediatric Hematology/Oncology Research Center of Excellence (NJ PHORCE) was established in 2021 is led by Dr. Peter Cole, the Embrace Kids Endowed Chair and Professor of Pediatric Hematology and Oncology. Its mission is to improve the lives of children diagnosed with cancer or blood disorders through research, training and education, community engagement, and public policy advocacy. To highlight just a few examples, current members of the Center are at the forefront of their research fields: in the biology of DNA repair; in the development of innovative targeted therapies; in preventing treatment-related toxicities; and in understanding disparities in treatment outcomes. Visit us at https://www.cinj.org/research/nj-pediatric-hematology-and-oncology-research-center-excellence-nj-phorce.

NJ PHORCE is based in the Rutgers Cancer Institute, New Jersey’s only NCI designated comprehensive cancer center. We offer world-class quality cancer care providing the most advanced medicines and treatment options for patients in its New Brunswick facility as well as at its network of hospitals across the state through the partnership with the Robert Wood Johnson Barnabas Health System and University Hospital in Newark.

For questions on this position or to learn more about our available positions, please contact the Rutgers Cancer Institute Faculty Recruitment Office at cinjcareers@rutgers.edu.

Apply at https://jobs.rutgers.edu/postings/210813

Candidates must have PhD or MD/PhD. Preference will be given to applicants with an established and extramurally funded research program with strong record of peer reviewed grant funding and publications.

About Rutgers Cancer Institute

Rutgers Cancer Institute together with RWJBarnabas Health is one of an elite group of comprehensive and consortium cancer centers in the U.S. designated by the National Cancer Institute and the only one in the state of New Jersey. This coveted designation gives Rutgers Cancer Institute the distinction of being among the best cancer research institutions in the nation. Rutgers Cancer Institute includes faculty members from across Rutgers University (including Rutgers Robert Wood Medical School, Rutgers Biomedical and Health Sciences) and Princeton University. We are a leader in basic, clinical, prevention, and public health science, offering world-class quality cancer care providing the most advanced medicines and treatment options for patients in our health system network across the state. Rutgers Cancer Institute is a cornerstone of New Jersey’s premier academic health center, Rutgers Biomedical and Health Sciences (RBHS). Construction is currently underway for a new $750 million state-of-the-art Cancer Center adjacent to the current Rutgers Cancer Institute facility and Robert Wood Johnson University Hospital. The 510,000 square foot Jack and Sheryl Morris Cancer Center wil...l be the state’s first free-standing cancer hospital. It will feature outpatient and inpatient clinical space—including 84 infusion bays, 74 exam rooms, and 96 inpatient beds. This is in addition to state-of-the-art laboratories where critical scientific investigation will be amplified, enabling physician-scientists to translate findings directly to patients. The Jack and Sheryl Morris Cancer Center will also have the capacity to offer wellness and education resources all in one location.

Show more

Show less

Connections working at Rutgers Cancer Institute